AIM
ALIM

Acrospire Investment Management’s Alimera Sciences ALIM Stock Holding History

Acrospire Investment Management’s Portfolio ALIM Stock Details ALIM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-701
Closed -$15K – 1528
2017
Q2 		$15K Sell
701
-1,557
-69% -$33.4K 0.01% 1672
2017
Q1 		$47K Buy
2,258
+1,412
+167% +$27.2K 0.04% 1019
2016
Q4 		$14K Buy
+846
New +$15.5K 0.01% 1878

Other funds holding ALIM

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACP
Acuta Capital Partners Redwood City, California $142M AUM 783.79% 1-Year Est. Return
JAM
JW Asset Management Miami Beach, Florida $244M AUM 71.51% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Acrospire Investment Management's ALIM Position: Q3 2017 in Review

Acrospire Investment Management sold out of Alimera Sciences (ALIM) in Q3 2017, closing a stake of 701 shares — an estimated $15K sold.

Acrospire Investment Management first reported a position in ALIM in Q4 2016 and held it in 3 quarters. The position peaked at $47K in Q1 2017. 41 funds tracked by Wall St. Rank hold ALIM as of Q3 2017.

  • Acrospire Investment Management reported no remaining Alimera Sciences position as of Q3 2017 after selling out during the quarter.
  • Acrospire Investment Management sold 701 Alimera Sciences shares in Q3 2017, an estimated $15K.
  • Acrospire Investment Management first reported a position in Alimera Sciences in Q4 2016 and held it in 3 quarters.
  • Acrospire Investment Management's Alimera Sciences position peaked at $47K in Q1 2017.
  • 41 funds tracked by Wall St. Rank held Alimera Sciences as of Q3 2017.

Based on Acrospire Investment Management's 13F filing for Q3 2017, filed 26 Oct 2017.